Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Tukysa
|
| gptkbp:acquisition |
Medi Gene AG (2018)
Astellas Pharma (2018) |
| gptkbp:awards |
Best Places to Work (2020)
Best Workplaces for Diversity (2020) Top 100 Best Companies to Work For (2021) Innovative Company Award (2019) Top 50 Biotech Companies (2021) |
| gptkbp:clinical_trial |
gptkb:healthcare_organization
gptkb:non-Hodgkin_lymphoma solid tumors |
| gptkbp:educational_programs |
Dr. Michael J. H. Smith
|
| gptkbp:employees |
approximately 1,000
|
| gptkbp:focus |
cancer therapeutics
|
| gptkbp:founded |
gptkb:1998
|
| gptkbp:founder |
Clayton A. Wright
|
| gptkbp:head_coach |
Dr. John O. Armitage
|
| gptkbp:headquarters |
gptkb:Bothell,_Washington
|
| https://www.w3.org/2000/01/rdf-schema#label |
Seattle Genetics
|
| gptkbp:key_people |
gptkb:Thomas_C._Reynolds
Clayton A. Wright |
| gptkbp:market_cap |
$20 billion (2021)
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer gptkb:Astellas_Pharma |
| gptkbp:production_company |
Dr. Sarah J. H. Brown
|
| gptkbp:products |
gptkb:Tukysa
gptkb:Adcetris |
| gptkbp:regulates |
Dr. Jennifer A. L. H. Lee
|
| gptkbp:research |
Dr. Roger Dansey
|
| gptkbp:research_focus |
biomarkers
targeted therapies immuno-oncology precision medicine antibody-drug conjugates |
| gptkbp:revenue |
$1.1 billion (2020)
|
| gptkbp:subsidiary |
Seattle Genetics Asia
Seattle Genetics Australia Seattle Genetics Canada Seattle Genetics Europe Seattle Genetics Japan |
| gptkbp:symbol |
gptkb:SGEN
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:type |
gptkb:Company
|
| gptkbp:website |
www.seattlegenetics.com
|